Ju-Fang Chang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Regulatory T Cells

Top Venues

Cancer immunology research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Ju-Fang Chang, Jack H Landmann, Tien-Ching Chang, Mehmet Emrah Selli, Yangdon Tenzin, John M Warrington, Julie Ritchey, Yu-Sung Hsu, Michael Joseph Slade, Deepesh Kumar Gupta, John F Dipersio, Alex S Holehouse, Nathan Singh
Rational protein engineering to enhance MHC-independent T cell receptors. Cancer discovery (2024)
Julie K Jadlowsky, Ju-Fang Chang, David H Spencer, John M Warrington, Bruce L Levine, Carl H June, Joseph A Fraietta, Nathan Singh
Regulatory Considerations for Genome-Edited T-cell Therapies. Cancer immunology research (2024)
Ju-Fang Chang, Nils Wellhausen, Nils Wolfgang Engel, Jack H Landmann, Caitlin R Hopkins, January Salas-McKee, Adham S Bear, Mehmet Emrah Selli, Sangya Agarwal, Julie K Jadlowsky, Gerald P Linette, Saar I Gill, Carl H June, Joseph A Fraietta, Nathan Singh
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors. Cancer immunology research 12 (9) (2024)
Ju-Fang Chang, Nils Wellhausen, Nils Wolfgang Engel, Jack H Landmann, Caitlin R Hopkins, January Salas-McKee, Adham S Bear, Mehmet Emrah Selli, Sangya Agarwal, Julie K Jadlowsky, Gerald P Linette, Saar I Gill, Carl H June, Joseph A Fraietta, Nathan Singh
Identification of core techniques that enhance genome editing of human T cells expressing synthetic antigen receptors. Cancer immunology research (2024)
Ju-Fang Chang, Jack H Landmann, Tien-Ching Chang, Mehmet Emrah Selli, Yangdon Tenzin, John M Warrington, Julie Ritchey, Yu-Sung Hsu, Michael Joseph Slade, Deepesh Kumar Gupta, John F Dipersio, Alex S Holehouse, Nathan Singh
Rational protein engineering to enhance MHC-independent T cell receptors. Cancer discovery (2024)
Julie K Jadlowsky, Ju-Fang Chang, David H Spencer, John M Warrington, Bruce L Levine, Carl H June, Joseph A Fraietta, Nathan Singh
Regulatory Considerations for Genome-Edited T-cell Therapies. Cancer immunology research 12 (9) (2024)